Onclive Team


Some Types of Prostate Cancer May Not be as Aggressive as Originally Thought

June 4th 2020

Researchers at the UCLA Jonsson Comprehensive Cancer Center analyze gene-expression patterns in the most aggressive prostate cancer grade group—known as Gleason grade group 5—and found that this grade of cancer can actually be subdivided into four subtypes with distinct differences.

FDA Approves Brigatinib for Frontline ALK+ NSCLC

May 23rd 2020

The FDA has approved brigatinib for the first-line treatment of patients with ALK-positive metastatic non–small cell lung cancer, as detected by an FDA-approved test.

CLR 131 Mechanism of Action

May 15th 2020

New Treatment Extends Lives of People With Most Common Type of Liver Cancer

May 14th 2020

For the first time in over a decade, scientists have identified a first-line treatment that significantly improves survival for people with hepatocellular carcinoma, the most common type of liver cancer.

Roswell Park to Assess Immunotherapy Combination in Cancer Patients With COVID-19

May 12th 2020

A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.

Novel and Emerging Therapeutic Interventions in Relapsed and Refractory Diffuse Large B-Cell Lymphoma

May 8th 2020

A panel of experts discuss the current and emerging treatment landscape of relapsed/refractory diffuse large B-cell lymphoma.

Treatment Selection, Sequencing, and, Unmet Needs in GEP-NETs

May 7th 2020

Hagen F. Kennecke, MD, discusses treatment selection, peptide receptor radionuclide therapy, and remaining challenges in the field of gastroenteropancreatic neuroendocrine tumors.

Expert Explains Latest Treatment Strategies in GEP-NETs

May 5th 2020

Aman Chauhan, MD, discusses recent developments and emerging therapies in gastroenteropancreatic neuroendocrine tumors.

Current and Emerging Treatments for Gastroenteropancreatic Neuroendocrine Tumors

May 4th 2020

During an OncLive® scientific interchange, panelists discussed the current treatment landscape for patients with gastroenteropancreatic-neuroendocrine tumors and the need for improved novel therapies.

Bispecific CD19/CD22 CAR T Cells Active in Pediatric Relapsed ALL

April 28th 2020

Treatment with CD19/22 chimeric antigen receptor CAR T cells induced a promising response in patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

SKCC Welcomes Dr. Kristin Brill as Enterprise Director of Breast Oncology

April 27th 2020

Breast surgeon Kristin L. Brill MD, has joined the Sidney Kimmel Cancer Center – Jefferson Health as Enterprise Director of Breast Oncology.

Dana-Farber Cancer Institute Faculty Recognized as 2020 ASCO Leaders in Cancer Care

April 25th 2020

The American Society of Clinical Oncology recognized four Dana-Farber Cancer Institute researchers as winners of ASCO's Special Awards, the Society’s highest honors.

Roswell Park Physicians Asked to Share Expertise in National Leadership Roles

April 22nd 2020

Two Roswell Park Comprehensive Cancer Center physicians are expanding their leadership roles across the United States and abroad with recent appointments in their respective fields of specialty.

OncLive News Network: On Location ASCO 2020

April 17th 2020

Join us LIVE at this year's virtual scientific program! OncLive® will broadcast a series of interviews with top thought leaders to share their insights and reactions to data presented during the virtual conference.

FDA Approves Mitomycin Gel for Urothelial Cancer

April 16th 2020

The FDA has approved mitomycin gel (Jelmyto) as the first therapy to treat low-grade upper tract urothelial cancer.

Margarett C. Ellison, MD of Gynecologic Oncology of Tallahassee Joins Florida Cancer Specialists and Research Institute

April 15th 2020

Florida Cancer Specialists & Research Institute is pleased to announce the addition of gynecologic-oncologist Dr. Margarett C. Ellison in Tallahassee.

Florida Cancer Specialists Launches Telehealth Services in Response to Coronavirus (COVID-19)

April 8th 2020

Florida Cancer Specialists & Research Institute (FCS) recently launched telehealth services across all FCS sites statewide, allowing patients continued and convenient access to care, while mitigating the impact and spread of COVID-19.

The US Oncology Network Names Renowned Cancer Researcher Robert L. Coleman, MD, Chief Scientific Officer

April 7th 2020

The US Oncology Network (The Network) has named prominent cancer researcher Robert L. Coleman, MD, FACOG, FACS, as its new Chief Scientific Officer.

Please Donate Blood!

April 2nd 2020

Amid the COVID-19 pandemic and in an effort to help our community, OncLive's parent company will be hosting the virtual MJH Life Sciences Sleeves Up Blood Drive from March 31 through April 30.

Roswell Park's Dr. Pawel Kalinski to Lead $14.5M NCI-Funded Immunotherapy Effort

March 31st 2020

A team led by Pawel Kalinski, MD, PhD, of Roswell Park Comprehensive Cancer Center has earned a five-year, $14.54 million award from the National Cancer Institute to expand a promising immunotherapy platform.